MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ABIOMED Company Profile (NASDAQ:ABMD)

Consensus Ratings for ABIOMED (NASDAQ:ABMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $113.11 (11.73% upside)

Analysts' Ratings History for ABIOMED (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2016Jefferies GroupReiterated RatingBuy$125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2016Benchmark Co.Reiterated RatingBuy$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Piper JaffrayReiterated RatingHold$75.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016BTIG ResearchReiterated RatingBuy$110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Raymond JamesUpgradeMarket Perform -> Outperform$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015Sterne Agee CRTReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015CRT CapitalInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015StephensReiterated RatingOverweight$103.00 -> $128.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Northland SecuritiesBoost Price TargetMarket Perform$60.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for ABIOMED (NASDAQ:ABMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q416$0.19$0.24$90.52 million$94.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2016Q316$0.15$0.23$80.04 million$85.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q2$0.13$0.17$74.56 million$76.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q116$0.08$0.20$66.27 million$73.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q415$0.12$0.28$62.55 million$67.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q315$0.04$0.30$53.20 million$62.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q215$0.02$0.03$48.80 million$51.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q115$0.01($0.04)$297.10 million$48.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q414$0.08$0.09$50.93 million$50.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q314$0.05$0.11$46.00 million$46.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2013Q214$0.03$0.03$43.75 million$44.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q1 2014$0.06($0.04)$42.93 million$42.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q4 2013$0.08$0.09$41.87 million$43.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q3 2013$0.07$0.07$38.04 million$38.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q213$0.05$0.20$37.47 million$37.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.10$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/16/2012$0.07$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2012($0.01)$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.09)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.06)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/18/2011($0.04)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011($0.09)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for ABIOMED (NASDAQ:ABMD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.12$0.20$0.16
Q2 20163$0.22$0.25$0.23
Q3 20164$0.19$0.28$0.25
Q4 20164$0.25$0.34$0.29
Q1 20176$0.20$0.29$0.24
Q2 20172$0.22$0.24$0.23
Q3 20172$0.29$0.33$0.31
Q4 20172$0.33$0.34$0.34
Q1 20181$0.30$0.30$0.30
Q2 20181$0.29$0.29$0.29
Q3 20181$0.43$0.43$0.43
Q4 20181$0.45$0.45$0.45
(Data provided by Zacks Investment Research)
Dividend History for ABIOMED (NASDAQ:ABMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for ABIOMED (NASDAQ:ABMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Andrew J GreenfieldVPSell9,000$104.16$937,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016David M WeberCOOSell4,342$96.97$421,043.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016David M WeberCOOSell5,604$94.56$529,914.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016David M WeberCOOSell2,145$93.82$201,243.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016David M WeberCOOSell52,000$95.27$4,954,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Paul ThomasDirectorSell7,500$95.14$713,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Andrew J GreenfieldVPSell10,000$99.10$991,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Michael G HowleyVPSell9,800$98.64$966,672.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Michael G HowleyVPSell200$98.80$19,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016Dorothy E PuhyDirectorSell10,000$95.02$950,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Andrew J GreenfieldVPSell15,000$94.11$1,411,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2016David M WeberCOOSell5,235$89.93$470,783.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Andrew J GreenfieldVPSell24,800$89.06$2,208,688.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Dorothy E PuhyDirectorSell10,000$90.30$903,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Andrew J GreenfieldVPSell19,572$89.07$1,743,278.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Andrew J GreenfieldVPSell200$89.00$17,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016David M WeberCOOSell17,521$85.20$1,492,789.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016William J BoltSVPSell17,510$85.19$1,491,676.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016David M WeberCOOSell8,111$85.21$691,138.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Dorothy E PuhyDirectorSell4,000$85.00$340,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016William J BoltSVPSell7,987$85.20$680,492.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Dorothy E. PuhyDirectorSell4,000$80.47$321,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Michael R. MinogueCEOSell146,800$104.87$15,394,916.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Dorothy E PuhyDirectorSell2,580$103.91$268,087.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Dorothy E PuhyDirectorSell2,580$105.27$271,596.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Michael G HowleyVPSell21,295$70.00$1,490,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Andrew J GreenfieldVPSell3,185$65.00$207,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Martin P SutterDirectorBuy7,500$60.17$451,275.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015David M WeberCOOSell17,968$60.77$1,091,915.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015Michael G HowleyVPSell17,353$66.47$1,153,453.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Andrew J GreenfieldVPSell3,500$71.00$248,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Robert BowenCFOSell2,372$71.52$169,645.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015David M WeberCOOSell1,605$73.72$118,320.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Michael R MinogueCEOSell8,840$73.12$646,380.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015William J BoltSVPSell1,750$74.27$129,972.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015David M WeberCOOSell3,765$71.08$267,616.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Andrew J GreenfieldVPSell15,000$31.90$478,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Michael R MinogueCEOSell164,000$31.14$5,106,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Michael R MinogueCEOSell82,383$26.30$2,166,672.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Andrew J GreenfieldVPSell7,026$21.10$148,248.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014David M WeberCOOSell10,172$21.11$214,730.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Michael R MinogueCEOSell90,001$21.19$1,907,121.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Robert BowenCFOSell6,820$21.11$143,970.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014William J BoltSVPSell8,029$21.10$169,411.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014David WeberCOOSell1,425$20.94$29,839.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Michael HowleyVPSell1,267$20.94$26,530.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Michael MinogueCEOSell4,433$20.94$92,827.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014William BoltSVPSell1,110$20.94$23,243.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Robert BowenCFOSell37,500$30.00$1,125,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013David WeberCOOSell6,500$24.00$156,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013William BoltSVPSell20,000$24.00$480,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013William BoltSVPSell21,534$23.35$502,818.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013David WeberCOOSell4,400$23.00$101,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Michael HowleyVPSell8,400$23.00$193,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013David WeberCOOSell7,100$22.90$162,590.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Michael HowleyVPSell1,600$23.03$36,848.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Robert BowenCFOSell2,235$22.64$50,600.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013W Gerald AustenDirectorSell8,000$22.85$182,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013William BoltSVPSell20,166$22.70$457,768.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2013Michael R MinogueCEOSell36,500$25.04$913,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Michael G HowleyVPSell10,000$24.45$244,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Robert BowenCFOSell40,786$23.50$958,471.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Robert BowenCFOSell1,499$23.50$35,226.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013David M WeberCOOSell6,519$21.20$138,202.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Michael G HowleyVPSell3,881$21.20$82,277.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Michael R MinogueCEOSell17,667$21.23$375,070.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Robert BowenCFOSell5,298$21.20$112,317.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013William J BoltSVPSell4,967$21.20$105,300.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Michael R MinogueCEOSell58,833$21.83$1,284,324.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013David M WeberCOOSell6,018$22.18$133,479.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Michael G HowleyVPSell5,476$22.18$121,457.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Robert BowenCFOSell5,102$22.18$113,162.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013William J BoltSVPSell4,629$22.18$102,671.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Andrew J GreenfieldVPSell1,666$21.63$36,035.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Michael R MinogueCEOSell5,666$21.62$122,498.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Robert BowenCFOSell2,715$23.50$63,802.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Michael R MinogueCEOSell20,000$21.00$420,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013Henri A TermeerDirectorBuy100,000$19.86$1,986,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2013Henri A TermeerDirectorBuy100,000$14.98$1,498,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for ABIOMED (NASDAQ:ABMD)
DateHeadline
06/27/16 07:02 AMWill ABIOMED, Inc. (NASDAQ:ABMD) Surprise This Quarter? - Investor Newswire
06/27/16 07:02 AMNext Weeks Broker Price Targets For ABIOMED, Inc. (NASDAQ:ABMD) - Fiscal Standard
06/26/16 07:02 AMStock Performance Focus on: ABIOMED, Inc. (NASDAQ:ABMD) - Press Telegraph
06/25/16 02:15 PMPalo Alto Investors LLC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $52.97 Million as Shares Rose - Engelwood Daily
06/24/16 07:28 PMNew Broker Ratings For ABIOMED, Inc. (NASDAQ:ABMD) - FTSE News
06/24/16 04:22 PMETF’s with exposure to ABIOMED, Inc. : June 24, 2016 -
06/21/16 07:23 AMABIOMED, Inc. breached its 50 day moving average in a Bullish Manner : ABMD-US : June 21, 2016 -
06/18/16 02:15 PMABIOMED, Inc. (NASDAQ:ABMD) Earnings Preview: Should Investors Be Nervous? - iStreetWire
06/17/16 02:15 PMABIOMED, Inc. (NASDAQ:ABMD) Analyst Rating in Focus - Investor Newswire
06/09/16 10:39 AMHow Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
06/07/16 07:08 AMAbiomed to Present at the William Blair 2016 Growth Stock Conference - [at noodls] - View printer-friendly version Back DANVERS, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael ...
06/06/16 07:53 PMABIOMED INC. (NASDAQ:ABMD) Financial Condition Compared to S&P 500 - CML News
06/05/16 10:08 AMPerformance Review for ABIOMED, Inc. (NASDAQ:ABMD) - HNN
06/05/16 10:08 AMABIOMED, Inc. (ABMD) Earns “Outperform” Rating from Leerink Swann - Let Me Know About This
06/04/16 02:16 PMPalo Alto Investors LLC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $52.97 Million as Shares Rose - CCH Daily News
06/03/16 08:17 PMThe Key Numbers To Watch From ABIOMED, Inc. (NASDAQ:ABMD)'s Earnings - iStreetWire
06/03/16 08:05 AMAbiomed to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - View printer-friendly version Back DANVERS, Mass., June 03, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael ...
06/02/16 10:53 AMStock Review and Earnings Check on ABIOMED, Inc. (NASDAQ:ABMD) - HNN - Stock Review and Earnings Check on ABIOMED, Inc. (NASDAQ:ABMD)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting ABIOMED, Inc. (NASDAQ:ABMD) to ...
06/02/16 10:53 AMEssex Woodlands Health Ventures INC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $65.80 Million as ... - CCH Daily News - Essex Woodlands Health Ventures INC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $65.80 Million as ...CCH Daily NewsEssex Woodlands Health Ventures Inc decreased its stake in Abiomed Inc (NASDAQ:ABMD) by 32.56% based on its latest 2016Q1 regulatory filing with the SEC. Essex Woodlands Health Ventures Inc sold 700,000 shares as the company's stock rose ...How Many ABIOMED, Inc. (NASDAQ:ABMD)'s Analysts Are Bearish?The Postall 2 news articles »
06/01/16 08:18 PMABIOMED, Inc. (NASDAQ:ABMD) Quarterly EPS Estimate At $0.25 - Investor Newswire - ABIOMED, Inc. (NASDAQ:ABMD) Quarterly EPS Estimate At $0.25Investor NewswireFirst Call stated that ABIOMED, Inc. (NASDAQ:ABMD) can touch $119.88 in coming one year. For the next quarter, the per-share earnings target is $0.25 and for ongoing fiscal at $1.13. EPS target for next year is $1.77 versus the mean EPS of $0.85 last year.and more »
05/31/16 07:57 PMABIOMED, Inc. (NASDAQ:ABMD) Set To Release Quarterly Earnings - Investor Newswire - ABIOMED, Inc. (NASDAQ:ABMD) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, ABIOMED, Inc. (NASDAQ:ABMD) is projected to report earnings of $0.34 for its recent quarter. The company plans to release its quarterly report on or around 2016-08-02. It should be ...and more »
05/31/16 08:07 AMResMed Continues to Rise after Phase 2 Study of CAT-HF -
05/30/16 09:16 PMPerformance at a Glance on ABIOMED, Inc. (NASDAQ:ABMD) - HNN - Performance at a Glance on ABIOMED, Inc. (NASDAQ:ABMD)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how ABIOMED, Inc. (NASDAQ:ABMD)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/30/16 09:16 PMRhenman & Partners Asset Management Ab Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $8.93 Million as ... - CCH Daily News - Rhenman & Partners Asset Management Ab Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $8.93 Million as ...CCH Daily NewsRhenman & Partners Asset Management Ab decreased its stake in Abiomed Inc (NASDAQ:ABMD) by 43.18% based on its latest 2016Q1 regulatory filing with the SEC. Rhenman & Partners Asset Management Ab sold 95,000 shares as the company's stock ...and more »
05/28/16 09:40 AMCoe Capital Management LLC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $6.23 Million as Shares Rose - CCH Daily News - Coe Capital Management LLC Decreased Stake in Abiomed INC (NASDAQ:ABMD) by $6.23 Million as Shares RoseCCH Daily NewsMark Coe decreased its stake in Abiomed Inc (NASDAQ:ABMD) by 77.7% based on its latest 2016Q1 regulatory filing with the SEC. Coe Capital Management Llc sold 66,272 shares as the company's stock rose 11.23% with the market. The hedge fund run by ...and more »
05/26/16 03:12 PMABIOMED INC Files SEC form 10-K, Annual Report -
05/23/16 03:42 PMETF’s with exposure to ABIOMED, Inc. : May 23, 2016 -
05/17/16 07:22 AMABIOMED, Inc. breached its 50 day moving average in a Bullish Manner : ABMD-US : May 17, 2016 -
05/05/16 09:40 AMABIOMED, Inc. :ABMD-US: Earnings Analysis: Q4, 2016 By the Numbers -
05/05/16 08:20 AMAbiomed (ABMD) Down despite Q4 Earnings & Revenue Beat -
05/03/16 11:57 AMAbiomed’s Impella Pumps Up Q4 Earnings, But Hot Stock Slows -
05/03/16 10:59 AMEdited Transcript of ABMD earnings conference call or presentation 3-May-16 12:00pm GMT -
05/03/16 07:17 AMABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
05/03/16 07:00 AMAbiomed Inc Earnings Call scheduled for 8:00 am ET today -
05/03/16 06:59 AMAbiomed beats Street 4Q forecasts -
05/03/16 06:10 AMAbiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year - [at noodls] - View printer-friendly version Back - Total Year Revenue of $329.5 Million, Up 43% Over Prior Year DANVERS, Mass., May 03, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough ...
05/03/16 06:07 AMQ4 2016 Abiomed Inc Earnings Release - Before Market Open -
04/29/16 09:01 AMAbiomed, Inc.: ABMD’s Rocky Road Is About to Clear Up - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Don't be scared off by Abiomed's competition. ABMD is in a great position: It's on an upward trajectory and it has a lot of buyout potential. The post Abiomed, Inc.: ABMD’s Rocky Road Is About to Clear Up appeared first on InvestorPlace.
04/29/16 08:52 AMAbiomed, Inc.: ABMD’s Rocky Road Is About to Clear Up - <p><a rel="nofollow" href="http://investorplace.com">InvestorPlace</a><a rel="nofollow" href="http://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Don't be scared off by Abiomed's competition. ABMD is in a great position: It's on an upward trajectory and it has a lot of buyout potential. </p> <p>The post <a rel="nofollow" href="http://investorplace.com/2016/04/abiomed-abmd-clear/">Abiomed, Inc.: ABMD’s Rocky Road Is About to Clear Up</a> appeared first on <a rel="nofollow" href="http://investorplace.com">InvestorPlace</a>.</p>
04/28/16 07:21 AM3 Scorching Hot Med-Tech Stocks In 2016 -
04/09/16 01:22 PMEarnings View for ABIOMED, Inc. (NASDAQ:ABMD) - RiversideGazette.com - Earnings View for ABIOMED, Inc. (NASDAQ:ABMD)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $0.18 on shares of ABIOMED, Inc. (NASDAQ:ABMD). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around 2016-05-03 for ...and more »
04/09/16 01:22 PMAbiomed (ABMD) Receives FDA Pre-Market Approval for Impella Therapy for Cardiogenic Shock - StreetInsider.com - Motley FoolAbiomed (ABMD) Receives FDA Pre-Market Approval for Impella Therapy for Cardiogenic ShockStreetInsider.comAbiomed, Inc. (NASDAQ: ABMD) announced that it has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps to provide treatment of ongoing cardiogenic shock.ABIOMED, Inc. (ABMD) Downgraded by Zacks Investment Research to HoldThe Vista VoiceAnalyst Review: ABIOMED, Inc. (NASDAQ:ABMD)Risers & FallersABIOMED Inc. (ABMD) Is Climbing After FDA Approves ImpellaRTT NewsTheStreet.com -Wall Street 24 -The Sussex Pilotall 26 news articles »
04/09/16 09:45 AM3 Charts Show Why Abiomed Could Get Bought - Growth and solid financial footing may be intriguing to an acquirer, but valuation may keep buyers away.
04/08/16 12:04 PMABIOMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
04/08/16 10:05 AMFDA approval nearly doubles potential U.S. patients for Abiomed’s heart pump -
04/07/16 04:48 PMAbiomed wins FDA approval for device to treat cardiac shock -
04/07/16 04:07 PMFDA approves Abiomed's device to treat cardiac shocks - [Reuters] - The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading. The most common cause of the shock is damage to the heart muscles from a severe heart attack. On an average, only about 7 percent of people who have heart attacks develop the condition, according to the National Institutes of Health.
04/07/16 09:22 AMWhy Abiomed Shares Jumped 13% in March - An FDA approval could lead to greater use of its Impella heart pumps.
04/05/16 09:25 AMThe Worst Mistakes Abiomed, Inc. Investors Can Make Right Now - If you've been riding the Abiomed gondola for years, now's the time to play wait-and-see for two important reasons.
03/30/16 12:20 PMRead This Before You Sell Abiomed, Inc. Stock - Abiomed's volatile stock looks overbought, but here's what you should know before you decide to hit the "sell" button.
About ABIOMED

ABIOMED logoAbiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company's products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABMD
  • CUSIP: 00365410
Key Metrics:
  • Previous Close: $100.37
  • 50 Day Moving Average: $99.53
  • 200 Day Moving Average: $91.11
  • P/E Ratio: 118.56
  • P/E Growth: 3.35
  • Market Cap: $4.28B
  • Current Quarter EPS Consensus Estimate: $1.13 EPS
Additional Links:
ABIOMED (NASDAQ:ABMD) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha